Augmentin for Sinus Infection
For adults with acute bacterial sinusitis, amoxicillin with or without clavulanate is first-line therapy, but recent evidence suggests standard-dose amoxicillin alone (875 mg twice daily) may be preferred over amoxicillin-clavulanate for uncomplicated cases, with equivalent efficacy and fewer adverse events. 1, 2
Adults
When to Use Antibiotics
Not all sinusitis requires antibiotics. The 2025 AAO-HNS guideline emphasizes watchful waiting as an initial strategy for all patients with uncomplicated acute bacterial rhinosinusitis (ABRS), regardless of severity 1. Antibiotics should be reserved for:
- Symptoms persisting >10 days without improvement
- Severe symptoms (high fever ≥39°C, purulent nasal discharge, facial pain) for 3-4 consecutive days
- Worsening symptoms after initial improvement ("double sickening")
Antibiotic Selection
First-line choice:
- Amoxicillin 875 mg twice daily is now preferred for uncomplicated cases 2
- Amoxicillin-clavulanate (Augmentin) 875-125 mg twice daily is an acceptable alternative 1
A landmark 2026 study of 234,608 adults found no difference in treatment failure between amoxicillin-clavulanate and amoxicillin alone (3.0% vs 3.1%), but amoxicillin-clavulanate was associated with significantly higher rates of yeast infections (1.1% vs 0.8%) and C. difficile infections (0.04% vs 0.02%) 2. This represents a major shift from the 2015 guideline recommendation.
When to use amoxicillin-clavulanate specifically:
- Recent antibiotic use (within 30 days)
- High local resistance rates of β-lactamase-producing H. influenzae
- Moderate-to-severe illness
- Comorbidities (though recent data questions this—see below)
Duration
7 days is sufficient for most adults with acute bacterial sinusitis 3. Despite this, 75% of prescriptions exceed 7 days in practice—a clear opportunity for improvement 3.
High-Dose Considerations
High-dose amoxicillin-clavulanate (2000-125 mg extended-release twice daily) showed no benefit over standard dosing in recent trials 4. A 2021 study stopped early for futility when high-dose therapy provided no advantage (44.3% vs 36.4% improvement at day 3, P=0.35) 4. Reserve high-dose therapy only for documented resistant organisms.
Children (3 months to 18 years)
Antibiotic Selection
For uncomplicated cases (age ≥2 years, no recent antibiotics, no daycare):
- Amoxicillin 45 mg/kg/day divided twice daily 5
For moderate-to-severe illness or risk factors:
- High-dose amoxicillin-clavulanate 90 mg/kg/day (of amoxicillin component) with 6.4 mg/kg/day clavulanate, divided twice daily 5, 6
- Maximum 2 g per dose
Risk factors requiring high-dose therapy:
- Age <2 years
- Daycare attendance
- Recent antibiotic use (within 30 days)
- Moderate-to-severe symptoms
- High local prevalence of resistant S. pneumoniae (>10%)
Duration
Minimum 10 days, or continue for 7 days after symptom resolution 5. This individualized approach ensures adequate treatment while avoiding unnecessarily prolonged courses.
Special Formulation Note
AUGMENTIN ES-600 (600 mg/42.9 mg per 5 mL) is NOT interchangeable with other Augmentin suspensions due to different clavulanate concentrations 7. Use the dosing chart provided with ES-600 based on body weight.
Key Clinical Pitfalls
Comorbidities May Not Require Broader Coverage
A 2026 study challenged conventional wisdom: among 38,810 adults with comorbidities and ARS, amoxicillin and amoxicillin-clavulanate had equivalent treatment failure rates 8. Chronic sinusitis was actually more frequent with amoxicillin-clavulanate. This suggests narrow-spectrum therapy (amoxicillin alone) may be appropriate even in patients with comorbidities.
Reassess at 72 Hours
If symptoms worsen or fail to improve within 72 hours, consider treatment failure 5. This is when you should:
- Switch antibiotics (e.g., from amoxicillin to amoxicillin-clavulanate, or to a respiratory fluoroquinolone)
- Consider imaging
- Refer to ENT if complications suspected
Penicillin Allergy
The risk of cross-reactivity with second- and third-generation cephalosporins is negligible in patients with penicillin allergy 5. Cefdinir, cefpodoxime, or ceftriaxone are reasonable alternatives.
Geographic and Setting Variations
Rural patients and those seen in urgent care are less likely to receive guideline-concordant therapy 3. Be especially vigilant about appropriate agent selection and duration in these settings.
Administration Tips
Take at the start of meals to minimize GI intolerance and enhance clavulanate absorption 7. Shake suspension well before each use. Refrigerate reconstituted suspension; stable for 10 days 7.